MUSTANG BIO, INC. Accounts Payable
MUSTANG BIO, INC. (MBIO) had Accounts Payable of $3.21 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-05
- 2026-06-30: Accounts Payable, Current $3.21M.
- 2026-03-31: Accounts Payable, Current $3.34M.
- 2025-12-31: Accounts Payable, Current $3.51M.
- 2025-09-30: Accounts Payable, Current $4.99M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $3.21M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $3.34M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $3.51M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $4.99M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $5.65M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $6.31M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $7.46M 10-K · filed 2026-03-19 |
| 2024-09-30 | $8.76M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $8.93M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $11.28M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $6.32M 10-K · filed 2025-03-28 |
| 2023-09-30 | $5.50M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $6.71M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $6.40M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $6.83M 10-K · filed 2024-03-11 |
| 2022-09-30 | $7.00M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $5.44M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $5.54M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $3.51M 10-K · filed 2023-03-30 |
| 2021-09-30 | $4.63M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $2.94M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $2.92M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $3.52M 10-K · filed 2022-03-23 |
| 2020-09-30 | $3.42M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $4.83M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $2.48M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.88M 10-K · filed 2021-03-24 |
| 2018-12-31 | $1.39M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |